
Background: Rapid estimation of drug-related properties accelerates the drug discovery process. Integration of computational methods leverages the drug discovery pipeline. The early-stage detection of Absorption Distribution Metabolism Excretion Toxicity (ADMET) properties reduces the time and experimental costs. The study aimed to evaluate the ADMET properties (Pharmacokinetic properties were predicted using pkCSM) of 27 compounds present in the Centella asiatica plant against the inhibitory potential of proteins escalated in keratinocyte proliferation of psoriasis. Methods: Chemical structures were optimised, and ADMET properties- LogS, LogP, Caco2, Cytochrome P450 (CYP450), human Ether a-go-go Related Gene (hERG) inhibition, Lethal Dose 50% (LD50), and Maximum allowable dosage- were measured using SWISSADME and pkCSM web servers. Data analysis included Pearson correlation, Principal Component Analysis (PCA), and hierarchical clustering. Molecular docking simulation was performed using AutoDock Vina software (Discovery Studio). Results: Correlation analysis reveals the interrelationship between LogS and LogP, with clustering based on similar properties. Molecular docking studies reveal the favourable binding affinity of the drug molecules with the targeted proteins IL-17A, IL-23, and IL-6. Conclusion: Advanced computational tools and their reproducibility of drug-related properties are useful for the drug discovery process. The present approach enabled us to identify the potential natural compound with anti-psoriatic activity. Natural therapies are useful for long-term use, and they may produce fewer adverse effects. Major Findings: Computational ADMET profiling and docking revealed caffeoylquinic acids, flavonoids, and triterpenoids from Centella asiatica as promising antipsoriatic agents with strong binding to IL17A, IL23, and IL6. These natural compounds demonstrated favourable pharmacokinetic properties and inhibitory potential, supporting their use as safer longterm therapeutic candidates.
Background: Wound healing is a clinical issue, especially in relation to chronic wounds, and this requires increased therapeutic action by the use of traditional medicinal plants. Sida acuta Burm.f. is a commonly used folk medicine containing bioactive compounds that have the potential to be used therapeutically, but it has low bioavailability. Aim: The proposed study seeks to develop phytosomes with hydroalcoholic extract of S. acuta leaves to improve wound healing due to the ability to deliver drugs. Methods: Soxhlet extraction using hydroalcoholic solvent (70% v/v ethanol) yielded 8.02% w/w extract, which was subjected to preliminary phytochemical screening. Phytosomes were prepared by antisolvent precipitation using soy lecithin at a 1:1 extract-to-phospholipid ratio. The formulation was characterised by FTIR spectroscopy, particle size, polydispersity index, and zeta potential. In vitro cytocompatibility was evaluated using the MTT assay in Vero cells, and wound-healing activity was assessed using the scratch assay. Results: The successful formation of phytosomes was established by FTIR, with the presence of characteristic peak displacements, which showed that it forms molecular interactions. Phytosomes had a 2529.0 nm particle size, 0.626 polydispersity index and -44 mV zeta potential. Cytotoxicity experiments produced an outstanding biocompatibility (IC50: 27.9 Mg/mL). The scratch assay revealed that there was a considerable degree of wound healing with 53.33% and 75.75% closure at 24 and 48 hrs respectively, which revealed that cell migration was increased as opposed to the control. Conclusion: The evidence indicates that S. acuta phytosomes are promising wound healing agents that can be used to combine both traditional and modern phospholipid-based delivery systems to promote better therapeutic effect. Major Findings: Sida acuta phytosomes showed relatively low cytotoxicity within the tested concentration range and demonstrated 53.33% and 75.75% wound closure at 24 and 48 h, respectively, supporting their potential for further in vitro and in vivo investigation.
Background: Samsarjana Krama, the graduated post-Shodhana dietary regimen described in classical texts like the Charaka Samhita and Ashtanga Hridayam, offers a systematic protocol for dietary re-introduction during convalescence. Standardised, nutritionally validated modern formulations aligned with this framework remain limited, despite growing interest in millets as nutrient-dense functional foods. Aim: To develop, standardise, and nutritionally characterise four millet-based ready-to-cook/reconstitute formulations, Peya, Vilepi, Akrita Yusha, and Krita Yusha, aligned with Samsarjana Krama principles, using millets selected through multi-drying method optimisation. Methods: Eight millet varieties (Finger, Great, Pearl, Proso, Foxtail, Little, Barnyard, Browntop) were sprouted and subjected to oven, sun, and shade drying, then screened for proximate composition. Proso millet (highest carbohydrate: 70.04%) and Foxtail millet (highest protein: 11.74%) were selected for their compatibility with respective preparations. Twelve formulations (P1–P3, V1–V3, A1–A3, K1–K3) were developed using standardised processing soaking, sprouting, drying, roasting, dehulling, autoclaving, and freeze-thaw cycling and evaluated for proximate, mineral, and antinutrient composition. Results: Krita Yusha formulations showed the highest nutritional density, with protein ranging from 16.53–20.53 g/100 g, calcium up to 75.91 mg, and potassium up to 583.06 mg/100 g, attributed to synergistic contributions from Pippali, Turmeric, Ginger, Mustard, and Curry leaves. Antinutrient levels of phytates (288–525 mg), tannins (0.21–0.37 g), and oxalates (18.47–23.25 mg) remained within acceptable dietary safety thresholds across formulations. Conclusion: The standardised millet-based Samsarjana Krama formulations represent a validated, scalable, and nutritionally adequate modern adaptation of classical convalescent dietary protocols. Major Findings: Krita Yusha formulations demonstrated the highest protein, calcium, and potassium content among all preparations, while antinutrients remained within safe limits, confirming the nutritional adequacy of these millet-based Samsarjana Krama formulations.
Metabolic syndrome (MetS) represents a multifactorial disorder characterised by insulin resistance, central obesity, dyslipidemia, and hypertension, predisposing individuals to type 2 diabetes mellitus, cardiovascular disease, and related chronic conditions. Conventional pharmacotherapy often targets individual components of MetS, but may be limited by side effects, partial efficacy, and poor long-term adherence. Dietary interventions, particularly the use of spices rich in bioactive phytochemicals, offer a promising complementary strategy for managing MetS through multi-targeted mechanisms. Culinary spices such as cinnamon, turmeric, ginger, garlic, black pepper, fenugreek, cardamom, coriander, clove, curry leaf, chia seed, Panax ginseng, and black seed exhibit hypoglycemic, hypolipidemic, antihypertensive, antioxidant, and anti-inflammatory properties. Such bioactive constituents modulate key metabolic pathways, including insulin signalling, glucose uptake, lipid metabolism, adipokine regulation, and oxidative stress mitigation. Clinical and preclinical evidence supports their efficacy in improving glycemic control, lipid profile, blood pressure, endothelial function, and inflammatory status, thereby reducing cardiometabolic risk. Major Finding: Collectively, the integration of such spices into dietary regimens represents a safe, cost-effective, and comprehensive approach for the anticipation and management of metabolic syndrome.
Background: The increasing prevalence of diabetic multidrug-resistant (MDR) pathogens has reduced the effectiveness of conventional antibiotics, highlighting the need for alternative therapies such as Ayurveda-derived plant bioactive compounds. Aim: This review aims to evaluate the potential of Ayurveda plant-derived natural bioactive compounds in combating diabetic multidrug-resistant (MDR) pathogens amid the growing global threat of antibiotic resistance. Methods: A comprehensive analysis of previous literature was conducted to examine the antibacterial efficacy of plant-derived bioactive compounds and their mechanisms of action against resistant pathogens. Emerging therapeutic strategies, including major plant materials and bioactive compounds, bacteriophages, nanotechnology, CRISPR-Cas systems, and probiotics, were also reviewed. Results: Plant-derived compounds demonstrate significant antimicrobial activity against MDR pathogens, including Gram-negative bacilli and Gram-positive cocci. These pathogens are responsible for infections that are increasingly difficult to treat with conventional antibiotics such as antifungal, antibacterial, and antiparasitic agents. Resistance mechanisms include efflux pumps, enzymatic degradation, and target site modification. Bioactive compounds such as alkaloids, flavonoids, terpenes, phenolic compounds, essential oils, and polysaccharides contribute to antimicrobial activity. Conclusion: Medicinal plant-derived compounds hold strong potential as alternative therapeutic agents against diabetic multidrug-resistant pathogens. However, variability in phytochemical activity and limitations in clinical validation highlight the need for standardisation, advanced technologies, and well-structured clinical trials. Global collaboration is needed to translate plant-based compounds into approved clinical treatments. Emphasis on personalised medicine may further enhance the effectiveness of these therapies in targeting specific microorganisms. Major Findings: Medicinal plant-derived bioactive compounds exhibit very strong antibacterial activity against diabetic multidrug-resistant microorganisms by targeting multiple resistance mechanisms, indicating their potential as effective alternative therapeutic options.